Vitamin D deficiency is common in the UK due to limited sunlight and modern indoor lifestyles. Treatment is essential to restore healthy vitamin D levels, support bone and muscle health, and prevent complications such as osteomalacia (adults) and rickets (children).

This UK-focused guide summarises medically approved treatment approaches, recommended doses, special considerations, and follow-up monitoring based on national guidelines.

Understanding How Vitamin D Deficiency Is Treated in the UK

Treatment depends on:

• Severity of deficiency

• Age

• Medical conditions

• Absorption ability

• Lifestyle and sun exposure

• Pregnancy or breastfeeding status

The goal of treatment is to:

• Restore vitamin D to a safe, sufficient level

• Correct calcium and phosphate abnormalities

• Reduce elevated parathyroid hormone (PTH)

• Prevent long-term skeletal complications

In the UK, vitamin D levels >50 nmol/L are considered sufficient for most individuals (SACN/NHS).

The Form of Vitamin D Used in the UK

1. Vitamin D3 (Colecalciferol)

This is the preferred form for most adults and children because it:

• Raises levels more effectively

• Has a longer half-life

• Is more potent than vitamin D2

Available over the counter and via NHS prescription.

2. Vitamin D2 (Ergocalciferol)

Used less commonly but may be prescribed when:

• Vegan-certified formulations are needed

• High-dose preparations (50,000 IU) are used in hospital/clinical settings

Most UK maintenance therapy uses Vitamin D3.

UK Treatment Guidelines Based on Severity

The NHS does not use American ng/mL ranges. Instead, clinical decisions are based on the nmol/L scale.

Deficiency = <25 nmol/L

Treatment required.

Insufficient = 25-50 nmol/L

Supplement recommended.

Sufficient = >50 nmol/L

No treatment needed unless symptoms or risk factors are present.

Treatment Regimens Used in the UK

NICE and MHRA guidance recognises two main treatment approaches for adults with deficiency:

1. Loading Dose Treatment (for deficiency <25 nmol/L)

Given over 6-10 weeks to quickly restore levels.

Common NHS-prescribed regimens include:

Colecalciferol loading:

• 20,000 IU (500 micrograms) once weekly for 6 weeks, OR

• 20,000 IU twice weekly for 7 weeks, OR

• 50,000 IU weekly for 6 weeks (less common now, but still used in local NHS trusts)

A total loading dose of 300,000 IU is typical across many NHS protocols.

After completing the loading phase:
→ Begin maintenance therapy (see below).

2. Daily Moderate-Dose Therapy (alternative approach)

Some clinicians prefer daily dosing, such as:

• 800-2,000 IU (20–50 micrograms) daily for 2-3 months

Useful for:

• Mild deficiency

• Patients unable to tolerate large weekly doses

• Elderly individuals

• People with malabsorption (dose may be higher)

Maintenance Therapy After Correction

Once deficiency is corrected:

Adults (NHS)

• 10 micrograms (400 IU) daily for the general population

• 800-2,000 IU daily for people at higher risk or with recurrent deficiency

Maintenance therapy is essential because vitamin D levels will fall again without ongoing supplementation.

High-risk groups may require:

• 1,000-2,000 IU daily long-term

• Year-round supplementation

Treatment for Special Groups (UK Guidelines)

Pregnant & Breastfeeding Women

NHS recommendation:

• 10 micrograms (400 IU) daily
  For deficiency:

• GP may prescribe higher doses short-term, followed by maintenance.

Infants and Children

• Breastfed babies: 8.5-10 micrograms daily (340-400 IU)

• Children 1-4 years: 10 micrograms daily (400 IU)

• Older children with deficiency: paediatrician may prescribe weight-adjusted vitamin D therapy

Severe cases (e.g., rickets) require specialist management.

Older Adults (65+)

Reduced skin synthesis makes deficiency common.
Treatment typically includes:

• Loading dose if deficient

• Long-term maintenance 800-2,000 IU/day

People With Obesity

Vitamin D is stored in fat tissue, reducing bioavailability.
Higher doses may be required, often:

• 2,000 IU/day maintenance
  or

• Higher loading dose under clinical supervision.

Malabsorption Disorders

Including:

• Coeliac disease

• Crohn’s disease

• Ulcerative colitis

• Cystic fibrosis

• Bariatric surgery

These patients may require:

• Higher doses

• Longer treatment durations

• Active vitamin D analogues in some cases

Kidney & Liver Disease

Patients with chronic kidney disease may need:

• Activated forms of vitamin D (alfacalcidol, calcitriol)
  as the kidneys cannot convert vitamin D properly.

Liver disease may reduce conversion to 25(OH)D and requires careful monitoring.

Safe Use of High-Dose Vitamin D (MHRA Guidance)

High-dose vitamin D (e.g., 20,000-50,000 IU) must only be taken under medical supervision.

Avoid high doses in:

• Sarcoidosis

• Granulomatous disease

• Hyperparathyroidism

• Kidney disease (unless specialist-managed)

• Anyone with high calcium levels

Monitoring is essential to prevent toxicity.

The Role of Calcium & Magnesium in Treatment

Calcium

NHS recommends adequate dietary calcium to support bone health.

Most adults need:

• 700 mg/day (from diet)
  Supplementation is not routine unless dietary intake is low.

Excess calcium supplementation increases the risk of kidney stones.

Magnesium

Magnesium supports vitamin D activation, but:

• Supplements are not routinely prescribed

• Should only be taken if dietary intake is low or deficiency is confirmed

Sunlight and Diet in Vitamin D Recovery

While supplements are essential for deficiency, lifestyle measures help:

Safe Sunlight Exposure

In the UK:

• From late March to early September, short periods outdoors help

• Never avoid sunscreen for the purpose of increasing vitamin D

• No vitamin D can be produced in UK winter sunlight

Dietary Sources

Include:

• Oily fish (salmon, sardines, mackerel)

• Egg yolks

• Liver

• Fortified foods such as cereals and plant milks

Diet alone is rarely enough to correct deficiency.

Monitoring & Follow-Up Testing (UK Clinical Practice)

When to Retest

• 8-12 weeks after completing a loading dose

• 3-6 months after starting maintenance therapy

• Annually for long-term management or high-risk groups

Blood tests may include:

• 25(OH)D

• Calcium

• Phosphate

• PTH (if bone disease suspected)

• Kidney and liver function (in relevant conditions)

Adjustments are made if:

• Levels remain low

• Hypercalcaemia occurs

• Symptoms persist

• Malabsorption is suspected

Summary: Safe, Effective Treatment Prevents Long-Term Complications

In the UK, vitamin D deficiency is highly treatable.
Key principles of treatment:

• Use clinically approved loading or daily regimens

• Switch to ongoing maintenance

• Monitor with follow-up blood tests

• Consider medical conditions and special populations

• Avoid high-dose therapy without GP or specialist oversight

With the correct guidance approach, patients can safely restore healthy vitamin D levels and prevent long-term bone, muscle, and immune complications.